Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Common Equity (2020 - 2025)

Historic Common Equity for Beauty Health (SKIN) over the last 6 years, with Q3 2025 value amounting to $65.7 million.

  • Beauty Health's Common Equity rose 993.91% to $65.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $65.7 million, marking a year-over-year increase of 993.91%. This contributed to the annual value of $51.8 million for FY2024, which is 1277.49% down from last year.
  • Latest data reveals that Beauty Health reported Common Equity of $65.7 million as of Q3 2025, which was up 993.91% from $74.0 million recorded in Q2 2025.
  • In the past 5 years, Beauty Health's Common Equity ranged from a high of $352.3 million in Q2 2022 and a low of -$142.1 million during Q3 2021
  • For the 5-year period, Beauty Health's Common Equity averaged around $111.6 million, with its median value being $69.2 million (2024).
  • Its Common Equity has fluctuated over the past 5 years, first tumbled by 60562003.41% in 2021, then surged by 209250.16% in 2022.
  • Quarter analysis of 5 years shows Beauty Health's Common Equity stood at $298.0 million in 2021, then tumbled by 43.95% to $167.1 million in 2022, then crashed by 64.45% to $59.4 million in 2023, then fell by 12.77% to $51.8 million in 2024, then rose by 26.75% to $65.7 million in 2025.
  • Its Common Equity stands at $65.7 million for Q3 2025, versus $74.0 million for Q2 2025 and $46.1 million for Q1 2025.